-
EP3649249
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3649249
| EP3649249 - METHOD FOR ASSESSING SUSCEPTIBILITY OF A VIRUS TO TREATMENT BY MEASURING ENZYME ACTIVITY AND A SYSTEM THEREFORE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 02.06.2023 Database last updated on 18.11.2024 | |
| Former | Request for examination was made Status updated on 10.04.2020 | ||
| Former | The international publication has been made Status updated on 12.01.2019 | Most recent event Tooltip | 29.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Cavidi AB Virdings Allé 2 754 50 Uppsala / SE | [2020/20] | Inventor(s) | 01 /
ENQVIST, Stina Sköldungagatan 35 753 35 Uppsala / SE | 02 /
KÄLLANDER, Clas Vallmarvägen 47 760 49 Herräng / SE | 03 /
GATU, Tommy Betgatan 9 754 49 Uppsala / SE | 04 /
MALMSTEN, Anders Birger Sjöbergsgatan 20 754 41 Uppsala / SE | 05 /
PETTERSSON, Ingvar Stagneliusgatan 3 754 27 Uppsala / SE | [2020/20] | Representative(s) | Zacco Sweden AB P.O. Box 5581 Löjtnantsgatan 21 114 85 Stockholm / SE | [N/P] |
| Former [2020/20] | Zacco Sweden AB P.O. Box 5581 114 85 Stockholm / SE | Application number, filing date | 18829128.0 | 03.07.2018 | [2020/20] | WO2018SE50726 | Priority number, date | SE20170050874 | 04.07.2017 Original published format: SE 1750874 | [2020/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019009793 | Date: | 10.01.2019 | Language: | EN | [2019/02] | Type: | A1 Application with search report | No.: | EP3649249 | Date: | 13.05.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.01.2019 takes the place of the publication of the European patent application. | [2020/20] | Search report(s) | International search report - published on: | SE | 10.01.2019 | (Supplementary) European search report - dispatched on: | EP | 03.02.2021 | Classification | IPC: | C12Q1/00, C12Q1/48, C12Q1/70, G01N33/94 | [2020/20] | CPC: |
C12Q1/485 (EP,US);
C12Q1/00 (EP);
C12Q1/025 (US);
G01N2333/005 (EP);
G01N2333/15 (US);
G01N2333/9128 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/20] | Title | German: | VERFAHREN ZUR BEURTEILUNG DER EMPFINDLICHKEIT EINES VIRUS GEGENÜBER EINER BEHANDLUNG DURCH MESSUNG DER ENZYMAKTIVITÄT UND SYSTEM DAFÜR | [2020/20] | English: | METHOD FOR ASSESSING SUSCEPTIBILITY OF A VIRUS TO TREATMENT BY MEASURING ENZYME ACTIVITY AND A SYSTEM THEREFORE | [2020/20] | French: | PROCÉDÉ D'ÉVALUATION DE LA SENSIBILITÉ D'UN VIRUS À UN TRAITEMENT PAR MESURE DE L'ACTIVITÉ ENZYMATIQUE ET SYSTÈME ASSOCIÉ | [2020/20] | Entry into regional phase | 14.01.2020 | National basic fee paid | 14.01.2020 | Search fee paid | 14.01.2020 | Designation fee(s) paid | 14.01.2020 | Examination fee paid | Examination procedure | 14.01.2020 | Examination requested [2020/20] | 17.08.2021 | Amendment by applicant (claims and/or description) | 02.06.2023 | Despatch of a communication from the examining division (Time limit: M04) | 19.09.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 17.07.2020 | Renewal fee patent year 03 | 01.06.2021 | Renewal fee patent year 04 | 20.06.2022 | Renewal fee patent year 05 | 28.06.2023 | Renewal fee patent year 06 | 29.05.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO9966068 (US GOV HEALTH & HUMAN SERV [US], et al) [Y] 1-13 * the whole document * * page 8, line 10 - page 10, line 25 * * page 16, line 11 - line 20 * * page 20, line 26 - line 29 * * page 36, line 12 - line 18 * * page 28, line 13 - line 14 *; | [YD]WO02103040 (CAVIDI TECH AB [SE], et al) [YD] 1-13* the whole document * | International search | [A]WO02103040 (CAVIDI TECH AB [SE], et al) [A] 1-13 * ; whole document *; | [A]WO9806873 (KAELLANDER CLAS [SE], et al) [A] 1-13 * ; whole document *; | [A]WO9624694 (SLOAN KETTERING INST CANCER [US]) [A] 1-13 * ; claims 17-27 * | [A] - Kajsa.Lowenhielm, "ExaVir TM Load, instruction version 3", Cavidi AB, (20111025), pages 1 - 13, URL: http://www.cavidi.se/wp-content/uploads/2014/06/ExaVir_Load_Instructions.pdf, XP055565859 [A] 1-13 * ; whole document * | [A] - GUPTA S. et al., "Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource limited settings?", BMJ Open, (20160000), vol. 6, page e008795, XP055565866 [A] 1-13 * ; whole document * DOI: http://dx.doi.org/10.1136/bmjopen-2015-008795 | [A] - FISCUS S. A. et al., "HIV-1 Viral Load Assays for Resource- Limited Settings", Plos medicine, (20061000), vol. 3, no. 10, page e417, XP055565871 [A] 1-13 * ; whole document * DOI: http://dx.doi.org/10.1371/journal.pmed.0030417 |